Pfizer tests new drug in people with kidney problems

NCT ID NCT07315360

Recruiting now Knowledge-focused Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 18 times

Summary

This study looks at how the body handles a single dose of the experimental drug PF-07328948 in adults with normal or reduced kidney function. About 28 participants aged 18 to 80 will take one tablet and stay at a clinic for 6 days for monitoring. The goal is to understand safety and drug processing, not to treat any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Genesis Clinical Research, LLC
RECRUITING

Tampa, Florida, 33603, United States
Nucleus Network
RECRUITING

Saint Paul, Minnesota, 55114, United States
Orange County Research Center
RECRUITING

Lake Forest, California, 92630, United States
Orlando Clinical Research Center
RECRUITING

Orlando, Florida, 32809, United States

Conditions

Explore the condition pages connected to this study.

HEALTHY RENAL IMPAIRMENT